These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of endothelin-1 and endothelin-3 on the release of prostanoids from isolated perfused rat kidney.
    Author: Trybulec M, Dudek RR, Gryglewski RJ.
    Journal: J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S229-32. PubMed ID: 1725341.
    Abstract:
    Endothelin-1 (ET-1) or endothelin-3 (ET-3) injected (0.1-100 pmol) into the renal artery of the isolated perfused rat kidney resulted in a dose-dependent increase in perfusion pressure (delta PP). In this respect, ET-1 was 30 times more potent than ET-3. Infusion of ET-1 (3 nM) for 3 min induced a pronounced and long-lasting rise in delta PP, in contrast to a transient increase in delta PP after a 3-min infusion of ET-3 (10 nM). The pressure effect of endothelins was associated with the appearance of 6-keto-PGF1 alpha and PGE2 but not TXB2 in the perfusate. ET-1 produced a transient release of comparable amounts of prostacyclin and PGE2. In contrast to ET-1, ET-3 evoked a sustained release of prostacyclin and PGE2 at a ratio 3:1. It is assumed that PGE2 contributed to the vasoconstrictor responses of the endothelins in the rat kidney because indomethacin (5.6 microM) attenuated the pressor responses induced by ET-1 to a larger extent than that induced by ET-3. These results are in line with earlier observations that PGE2 is a vasoconstrictor in rat kidney. The differential release of prostanoids by ET-1 and ET-3 suggests the existence of separate receptors for ET-1 and ET-3 in the rat kidney. ET-3 appears to be a good candidate for an endogenous regulator of the release of prostacyclin.
    [Abstract] [Full Text] [Related] [New Search]